Esperion Therapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:ESPR) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -85.18 M-263.81 M-174.83 M-135.49 M-23.65 M-13.09 M -18.19 M Cash from investing activities 21.36 M-50.48 M8.1 M42.5 M-317 K0 -189 K Cash from financing activities 201.72 M268.22 M32.61 M50.46 M86.48 M36.18 M 59.9 M Free cash flow -85.18 M-263.81 M-174.83 M-135.49 M-23.65 M-13.09 M -18.19 M

News

Why Is Altimmune (ALT) Down 11.3% Since Last Earnings Report?

Catalyst (CPRX) Up 0.6% Since Last Earnings Report: Can It Continue?

Epilogue On Esperion Therapeutics Stock (NASDAQ:ESPR)

ESPR Stock Surges 44% in a Month: Here's What You Need to Know

Esperion Therapeutics (ESPR) Down 10% Since Last Earnings Report: Can It Rebound?

Karyopharm Therapeutics (KPTI) Stock Jumps 6.9%: Will It Continue to Soar?

BofA reiterates Esperion Therapeutics stock Underperform rating

Bempedoic acid gains top-level guideline recommendations for cholesterol

Citizens raises Esperion Therapeutics price target on drug growth

ESPR's Q4 Earnings Lag Estimates, Revenues Beat, Stock Down

H.C. Wainwright reiterates Buy on Esperion stock, $16 target

Esperion Q4 2025 slides: 38% sales growth, $4.6B CHF opportunity